PPIDT00035
Drug Information
| Name | Oprelvekin |
|---|---|
| Sequence | GPPPGPPRVSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAMSAGALGALQLPGVLTRLRADLLSYLRHVQWLRRAGGSSLKTLEPELGTLQARLDRLLRRLQLLMSRLALPQPPPDPPAPPLAPPSSAWGGIRAAHAILGGLHLTLDWAVRGLLLLKTRL |
| DrugBank_ID | DB00038 |
| Type | biotech |
| Indication | Indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia.[Label] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Kit | Subcutaneous |
5 mg/1mL
|